Virios Therapeutics, Inc. (NASDAQ:VIRI – Get Free Report)’s share price fell 7.3% during mid-day trading on Tuesday . The stock traded as low as $2.77 and last traded at $2.78. 39,565 shares changed hands during trading, a decline of 96% from the average session volume of 1,049,645 shares. The stock had previously closed at $3.00.
Virios Therapeutics Trading Down 10.8%
The business has a 50 day moving average of $2.98 and a 200-day moving average of $4.65. The stock has a market cap of $44.49 million, a PE ratio of -8.56 and a beta of 1.58.
About Virios Therapeutics
Virios Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for fibrotic diseases. The company leverages its proprietary small-molecule platform to identify and advance compounds designed to modulate key pathways involved in scar formation and tissue repair. By concentrating on conditions with high unmet medical need, Virios aims to improve patient outcomes through more effective and safer treatment options.
The company’s lead development candidate, VTI-1002, is an oral small molecule inhibitor in clinical trials for the prevention and treatment of hypertrophic scars and keloids.
Featured Articles
Receive News & Ratings for Virios Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virios Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
